Bone morphogenetic proteins but not growth differentiation factors induce dopaminergic differentiation in mesencephalic precursors

Molecular and Cellular Neuroscience

Volumn 21, Issue 3, 2002, Pages 367-378

  Brederlau, Anke ^a   Faigle, R ^a   Kaplan, P ^b   Odin, P ^c   Funa, K ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CURIS INC   (United States)

^c Reinkenheide Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEIN 6; GROWTH DIFFERENTIATION FACTOR 5; GROWTH DIFFERENTIATION FACTOR 6; GROWTH FACTOR; MICROTUBULE ASSOCIATED PROTEIN 2; OSTEOGENIC PROTEIN 1; OSTEOGENIN; OXIDOPAMINE; SMAD PROTEIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL FATE; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DOPAMINERGIC NERVE CELL; DRUG EFFECT; EMBRYO; GLIA CELL; MACROGLIA; MESENCEPHALON; NERVE CELL DIFFERENTIATION; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PRECURSOR; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANIMALIA;

EID: 0036935247     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2002.1178     Document Type: Article

References (36)

1. Attisano, L., and Wrana, J. L. (2000). Smads as transcriptional co-modulators. Curr. Opin. Cell Biol. 12: 235-243.
2. Gross, R. E., Mehler, M. F., Mabie, P. C., Zang, Z., Santschi, L., and Kessler, J. A. (1996). Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron 17: 595-606.
3. Guo, X., Rueger, D., and Higgins, D. (1998). Osteogenic protein-1 and related bone morphogenetic proteins regulate dendritic growth and the expression of microtubule-associated protein-2 in rat sympathetic neurons. Neurosci. Lett. 245: 131-134.
4. Hattori, A., Katayama, M., Iwasaki, S., Ishii, K., Tsujimoto, M., and Kohno, M. (1999). Bone morphogenetic protein-2 promotes survival and differentiation of striatal GABAergic neurons in the absence of glial cell proliferation. J. Neurochem. 72: 2264-2271.
5. Heldin, C. H., Miyazono, K., and ten Dijke, P. (1997). TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471.
6. Jordan, J., Bottner, M., Schluesener, H. J., Unsicker, K., and Krieglstein, K. (1997). Bone morphogenetic proteins: Neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells. Eur. J. Neurosci. 9: 1699-1709.
7. Kramer, B. C., Goldman, A. D., and Mytilineou, C. (1999). Glial cell line derived neurotrophic factor promotes the recovery of dopamine neurons damaged by 6-hydroxydopamine in vitro. Brain Res. 851: 221-227.
8. Krieglstein, K., Strelau, J., Schober, A., Sullivan, A., and Unsicker, K. (2002). TGF-beta and the regulation of neuron survival and death. J. Physiol. Paris 96: 25-30.
9. Krieglstein, K., Suter-Crazzolara, C., Hotten, G., Pohl, J., and Unsicker, K. (1995). Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-beta superfamily, on midbrain dopaminergic neurons. J. Neurosci. Res. 42: 724-732.
10. Lee, K. J., Mendelsohn, M., and Jessell, T. M. (1998). Neuronal patterning by BMPs: A requirement for GDF7 in the generation of a discrete class of commissural interneurons in the mouse spinal cord. Genes Dev. 12: 3394-3407.
11. Li, W., Cogswell, C. A., and LoTurco, J. J. (1998). Neuronal differentiation of precursors in the neocortical ventricular zone is triggered by BMP. J. Neurosci. 18: 8853-8862.
12. Liem, K. F., Tremml, G., and Jessell, T. M. (1997). A role for the roof plate and its resident TGFbeta-related proteins in neuronal patterning in the dorsal spinal cord. Cell 91: 127-138.
13. Mabie, P. C., Mehler, M. F., and Kessler, J. A. (1999). Multiple roles of bone morphogenetic protein signaling in the regulation of cortical cell number and phenotype. J. Neurosci. 19: 7077-7088.
14. Macias-Silva, M., Hoodless, P. A., Tang, S. J., Buchwald, M., and Wrana, J. L. (1998). Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem. 273: 25628-25636.
15. Massague, J. (1996). Neurotrophic factors. Crossing receptor boundaries. Nature 382: 29-30.
16. Massague, J., and Wotton, D. (2000). Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 19: 1745-1754.
17. Mehler, M. F., Mabie, P. C., Zhu, G., Gokhan, S., and Kessler, J. A. (2000). Developmental changes in progenitor cell responsiveness to bone morphogenetic proteins differentially modulate progressive CNS lineage fate. Dev. Neurosci. 22: 74-85.
18. Miyazono, K. (2000). TGF-beta signaling by Smad proteins. Cytokine Growth Factor Rev. 11: 15-22.
19. Nikkhah, G., Eberhard, J., Olsson, M., and Björklund, A. (1995). Preservation of fetal ventral mesencephalic cells by cool storage: In-vitro viability and TH-positive neuron survival after microtransplantation to the striatum. Brain Res. 687: 22-34.
20. Nishitoh, H., Ichijo, H., Kimura, M., Matsumoto, T., Makishima, F., Yamaguchi, A., Yamashita, H., Enomoto, S., and Miyazono, K. (1996). Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J. Biol. Chem. 271: 21345-21352.
21. Nohno, T., Ishikawa, T., Saito, T., Hosokawa, K., Noji, S., Wolsing, D. H., and Rosenbaum, J. S. (1995). Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J. Biol. Chem. 270: 22522-22526.
22. Panchision, D. M., Pickel, J. M., Studer, L., Lee, S. H., Turner, P. A., Hazel, T. G., and McKay, R. D. (2001). Sequential actions of BMP receptors control neural precursor cell production and fate. Genes Dev. 15: 2094-2110.
23. Reiriz, J., Espejo, M., Ventura, F., Ambrosio, S., and Alberch, J. (1999). Bone morphogenetic protein-2 promotes dissociated effects on the number and differentiation of cultured ventral mesencephalic dopaminergic neurons. J. Neurobiol. 38: 161-170.
24. Rosenzweig, B. L., Imamura, T., Okadome, T., Cox, G. N., Yamashita, H., ten Dijke, P., Heldin, C. H., and Miyazono, K. (1995). Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc. Natl. Acad. Sci. USA 92: 7632-7636.
25. Shah, N. M., and Anderson, D. J. (1997). Integration of multiple instructive cues by neural crest stem cells reveals cell-intrinsic biases in relative growth factor responsiveness. Proc. Natl. Acad. Sci. USA 94: 11369-11374.
26. Shimoda, K., Sauve, Y., Marini, A., Schwartz, J. P., and Commissiong, J. W. (1992). A high percentage yield of tyrosine hydroxylase-positive cells from rat E14 mesencephalic cell culture. Brain Res. 586: 319-331.
27. Söderstrom, S., and Ebendal, T. (1999). Localized expression of BMP and GDF mRNA in the rodent brain. J. Neurosci. Res. 56: 482-492.
28. Strelau, J., Sullivan, A., Bottner, M., Lingor, P., Falkenstein, E., Suter-Crazzolara, C., Galter, D., Jaszai, J., Krieglstein, K., and Unsicker, K. (2000). Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. J. Neurosci. 20: 8597-8603.
29. Sullivan, A. M., Opacka-Juffry, J., Pohl, J., and Blunt, S. B. (1999). Neuroprotective effects of growth/differentiation factor 5 depend on the site of administration. Brain Res. 818: 176-179.
30. Sun, Y., Nadal-Vicens, M., Misono, S., Lin, M. Z., Zubiaga, A., Hua, X., Fan, G., and Greenberg, M. E. (2001). Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell 104: 365-376.
31. Takeshima, T., Shimoda, K., Sauve, Y., and Commissiong, J. W. (1994). Astrocyte-dependent and -independent phases of the development and survival of rat embryonic day 14 mesencephalic, dopaminergic neurons in culture. Neuroscience 60: 809-823.
32. ten Dijke, P., Yamashita, H., Sampath, T. K., Reddi, A. H., Estevez, M., Riddle, D. L., Ichijo, H., Heldin, C. H., and Miyazono, K. (1994). Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269: 16985-16988.
33. Tomizawa, K., Matsui, H., Kondo, E., Miyamoto, K., Tokuda, M., Itano, T., Nagahata, S., Akagi, T., and Hatase, O. (1995). Developmental alteration and neuron-specific expression of bone morphogenetic protein-6 (BMP-6) mRNA in rodent brain. Brain Res. Mol. Brain Res. 28: 122-128.
34. Varley, J. E., and Maxwell, G. D. (1996). BMP-2 and BMP-4, but not BMP-6, increase the number of adrenergic cells which develop in quail trunk neural crest cultures. Exp. Neurol. 140: 84-94.
35. Varley, J. E., McPherson, C. E., Zou, H., Niswander, L., and Maxwell, G. D. (1998). Expression of a constitutively active type I BMP receptor using a retroviral vector promotes the development of adrenergic cells in neural crest cultures. Dev. Biol. 196: 107-118.
36. Zhang, D., Mehler, M. F., Song, Q., and Kessler, J. A. (1998). Development of bone morphogenetic protein receptors in the nervous system and possible roles in regulating trkC expression. J. Neurosci. 18: 3314-3326.